Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic HCV Infection”

1,468 trials

Showing 20 of 1,468 results

Not applicableEnded earlyNCT03500562
What this trial is testing

Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 3
Not applicableStudy completedNCT00187473
What this trial is testing

Natural History of Hepatitis C in Patients With Normal Liver Tests

Who this might be right for
Chronic Hepatitis C
University of California, San Francisco 92
Large-scale testing (Phase 3)Study completedNCT01258686
What this trial is testing

Clinical Study With Silymarin in the Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiviral Therapy

Who this might be right for
Hepatitis C
Bukwang Pharmaceutical 53
Testing effectiveness (Phase 2)Study completedNCT01466790
What this trial is testing

TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients

Who this might be right for
Hepatitis C
Janssen R&D Ireland 168
Large-scale testing (Phase 3)Study completedNCT00249860
What this trial is testing

Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects

Who this might be right for
Hepatitis C
EMD Serono 257
Testing effectiveness (Phase 2)Study completedNCT01987453
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Participants With Chronic Genotype 1 HCV Who Participated in a Prior Gilead-Sponsored HCV Treatment Study

Who this might be right for
HCV Infection
Gilead Sciences 100
Testing effectiveness (Phase 2)Ended earlyNCT01425970
What this trial is testing

Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or Ribavirin

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 210
Post-approval studies (Phase 4)UnknownNCT03018353
What this trial is testing

Curing HCV in Incarcerated Patients

Who this might be right for
Hepatitis C, Chronic
San Francisco Department of Public Health 100
Testing effectiveness (Phase 2)Study completedNCT02226939
What this trial is testing

Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis C

Who this might be right for
Liver CirrhosisHepatitis C, Chronic
Boehringer Ingelheim 10
Large-scale testing (Phase 3)Study completedNCT02105467
What this trial is testing

Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060)

Who this might be right for
Chronic Hepatitis C Virus
Merck Sharp & Dohme LLC 421
Early research (Phase 1)Study completedNCT00905632
What this trial is testing

4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 75
Post-approval studies (Phase 4)Study completedNCT00087607
What this trial is testing

Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 385
Not applicableStudy completedNCT00466271
What this trial is testing

Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study

Who this might be right for
Chronic Hepatitis CHepatic Fibrosis
National Taiwan University Hospital 102
Large-scale testing (Phase 3)Study completedNCT01767116
What this trial is testing

Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1b Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie (prior sponsor, Abbott) 419
Post-approval studies (Phase 4)Study completedNCT03781726
What this trial is testing

Multi-center Study to Transplant Hepatitis-C Infected Kidneys

Who this might be right for
Renal Failure ChronicHepatitis C
Raymond Chung 30
Post-approval studies (Phase 4)Study completedNCT00553930
What this trial is testing

Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients

Who this might be right for
Hepatitis C, ChronicHIV Infections
Sociedad Andaluza de Enfermedades Infecciosas 71
Large-scale testing (Phase 3)UnknownNCT00437684
What this trial is testing

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

Who this might be right for
HIV InfectionsHepatitis C
IRCCS San Raffaele 50
Large-scale testing (Phase 3)UnknownNCT04070235
What this trial is testing

SH229 Tablets Combined With Daclatasvir Dihydrochloride Tablets in Treatment Adult Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Nanjing Sanhome Pharmaceutical, Co., Ltd. 440
Post-approval studies (Phase 4)UnknownNCT00834860
What this trial is testing

Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma

Who this might be right for
Chronic Hepatitis CHepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital 179
Testing effectiveness (Phase 2)Study completedNCT01849562
What this trial is testing

Safety, Tolerability, and Efficacy of 12-weeks of Sovaprevir, ACH-3102, and Ribavirin in Treatment-naive GT-1 HCV Participants

Who this might be right for
Hepatitis C, Chronic
Alexion Pharmaceuticals, Inc. 30
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation